Content-type: text/application/x-research-info-systems

TY  - JOUR
AU  - Barlesi, F
AU  - Tchouhadjian, C
AU  - Doddoli, C
AU  - Torre, J-P
AU  - Astoul, P
AU  - Kleisbauer, J-P
TI  - CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
JA  - Br J Cancer
PY  - 2004/12/14/online
VL  - 92
IS  - 1
SP  - 13
EP  - 14
PB  - Cancer Research UK
SN  - 0007-0920
UR  - http://dx.doi.org/10.1038/sj.bjc.6602296
ER  -